A double-blind placebo-controlled randomized trial of oral saffron in the treatment of rheumatoid arthritis | ||
Avicenna Journal of Phytomedicine | ||
دوره 11، شماره 4، مهر و آبان 2021، صفحه 332-342 اصل مقاله (668.08 K) | ||
نوع مقاله: Original Research Article | ||
شناسه دیجیتال (DOI): 10.22038/ajp.2020.17280 | ||
نویسندگان | ||
Maryam Sahebari1؛ Hossein Heidari1؛ Shima Nabavi1؛ Mandana Khodashahi1؛ Zahra Rezaieyazdi1؛ Maliheh DadgarMoghaddam2؛ Hossein Hosseinzadeh3؛ Shaghayegh Abbasi1؛ Kamila Hashemzadeh* 1 | ||
1Rheumatic Diseases Research Center, Mashhad University of Medical Sciences, Mashhad, Iran | ||
2Community Medicine Department, faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran | ||
3Department of Pharmacodynamics and Toxicology, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran. Pharmaceutical Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran | ||
چکیده | ||
Objective: Recently, saffron (Crocus sativus L. from the Iridaceae family) has been characterized by its antioxidant, anti-inflammatory and analgesic effects. This study aimed to evaluate the effect of saffron on disease activity in patients with rheumatoid arthritis (RA). Materials and Methods: This is a double-blind, placebo-controlled, randomized clinical trial (RCT) performed on 55 newly- diagnosed RA patients without previous treatment, who were randomly divided into intervention (included 28 cases) and control groups (consisted of 27 individuals). Standard therapy including prednisolone, oral methotrexate, folic acid, vitamin D, calcium, and alendronate, was administered similarly in both groups. Patients received a 100 mg saffron pill/day (pure saffron powder) or placebo besides the standard protocol. The placebo had the same shape as the saffron pills. Follow up of DAS28ESR disease activity score was done on the 30th, 45th and 90th day of the study. Results: There was no difference between the intervention and control groups regarding to the DAS28ESR at the end of the study. However, a significant decrease in DAS28-ESR was observed in each group compared to the first visit (p=0.001). The results also showed no significant difference in the incidence of side effects in both groups. Conclusion: In summary, patients who received pure saffron pills (100 mg/day) in addition to standard therapy did not have a significant difference in improvement of disease activity from the patients on standard therapy. | ||
کلیدواژهها | ||
Crocus sativus L؛ Iridaceae family؛ Saffron؛ Rheumatoid arthritis؛ Clinical trial؛ RCT | ||
مراجع | ||
Abdullaev F, Espinosa-Aguirre J.2004a. Biomedical properties of saffron and its potential use in cancer therapy and chemoprevention trials. Cancer detect prev, 28: 426-432. Abdullaev FI.1993a. Biological effects of saffron.BioFactors (Oxford, England), 4:83-86 Abdullaev FI. 2002a. Cancer chemopreventive and tumoricidal properties of saffron (Crocus sativus L.). Expbiol med, 227: 20- 25. Amin B, Hosseinzadeh H. 2012b. Evaluation of aqueous and ethanolic extracts of saffron, Crocus sativus L., and its constituents, safranal and crocin inallodynia and hyperalgesia induced by chronic constriction injury model of neuropathic pain in rats. Fitoterapia, 83: 888-895. Amin B, Hosseinzadeh H. 2015. Analgesic and anti-inflammatory effects of Crocus sativus L. (saffron) Bioactive nutraceuticals and dietary supplements in neurological and brain disease. Elsevier, p 319-324. Benucci M, Saviola G, Baiardi P, Manfredi M, Puttini PS, Atzeni F.2012. Determinants of risk infection during therapy with anti TNF-alpha blocking agents in rheumatoid arthritis. Open Rheumatol J, 6: 33. Bolhassani A, Khavari A, Bathaie SZ. 2014a. Saffron and natural carotenoids: Biochemical activities and anti-tumor effects. BiochimBiophysActa, 1845:20-30 Bruce B, FriesJ.F. 2009a. The Health Assessment Questionnaire (HAQ)© and the Improved HAQ. Clin Exp Rheumatol, 23: 14-18. Duesterdieck-Zellmer KF, Driscoll N, Ott JF.2012b. Concentration-dependent effects of tiludronate on equine articular cartilage explants incubated with and without interleukin-1β. Am J Vet Res, 73: 1530- 1539. Edwards C, Cooper C. 2006a. Early environmental factors and rheumatoid arthritis. Clin Exp Immunol, 143: 1-5. Fransen, J, Creemers MCW and Van Riel PLCM. 2004b. Remission in rheumatoid arthritis: agreement of the disease activity score (DAS28) with the ARA preliminary remission criteria. Rheumatology, 43: 1252-1255. Ghorbani M. 2008b. The efficiency of saffron’s marketing channel in Iran. World Appl Sci J, 4: 523-527. Gout B, Bourges C, Paineau-Dubreuil S. 2010b. Satiereal, a Crocus sativus L extract, reduces snacking and increases satiety in a randomized placebo-controlled study of mildly overweight, healthy women. Nutr Res, 30: 305-313. Hamidi, Z. and Aryaeian, N. and Abolghasemi, J. and Shirani, F. and Hadidi, M. and Fallah, S. and Moradi, N. 2020b. The effect of saffron supplement on clinical outcomes and metabolic profiles in patients with active rheumatoid arthritis: A randomized, double-blind, placebo-controlled clinical trial. Phytother Res, 34: 1650-1658. Hertzog, M.A., 2008a. Considerations in determining sample size for pilot studies. Res Nurs Health, 31:180-191. Hosseinzadeh H.2014a. Saffron: a herbal medicine of third millennium. Jundishapur j nat pharm prod, 9: 1. Hosseinzadeh H, Modaghegh MH, Saffari Z. 2009b. Crocus sativus L.(Saffron) extract and its active constituents (crocin and safranal) on ischemia-reperfusion in rat skeletal muscle. EVID-Based Compl Alt, 6: 343-350. Hosseinzadeh H, Younesi HM. 2002a. Antinociceptive and anti-inflammatory effects of Crocus sativus L. stigma and petal extracts in mice. BMC PharmacolToxicol, 2: 7. Hreggvidsdottir HS, Noordenbos T, Baeten DL. 2014a. Inflammatory pathways in spondyloarthritis. Mol Immunol, 57: 28-37. Hsu J, Chou F, Lee M, et al. 1999b. Suppression of the TPA-induced expression of nuclearprotooncogenes in mouse epidermis by crocetin via antioxidant activity. Anticancer Res, 19: 4221-4227. Javadi B, Sahebkar A, Emami SA. 2013a. A survey on saffron in major Islamic traditional medicine books. Iran J Basic Med Sci, 16: 1. Kasper D, Harrison TR. 2005. Harrison's principles of internal medicine. Vol. 2. McGraw-Hill, Medical Publishing Division Kay J, and Upchurch KS, 2012. ACR/EULAR 2010 rheumatoid arthritis classificationcriteria. Rheumatology, 51(su ppl_6), pp.vi5-vi9. Korani S, Korani M, Sathyapalan T, Sahebkar A. 2019. Therapeutic effects of Crocin in autoimmune diseases: A review. Sahebari et al. AJP, Vol. 11, No. 4, Jul-Aug 2021 342 BioFactors, 45(6), pp. 835-843. Lee I-A, Lee JH, Baek N-I, Kim D-H. 2005b. Antihyperlipidemic effect of crocin isolated from the fructus of Gardenia jasminoides and its metabolite crocetin. Biol Pharm Bull, 28: 2106-2110. Li X, Jiang C, Zhu W. 2017b. Crocin reduces the inflammation response in rheumatoid arthritis. Biosci Biotech Bioch, 81: 891- 898. Liu W, Sun Y, Cheng Z, Guo Y, Liu P, Wen Y. 2018a. Crocin exerts anti-inflammatory and anti-arthritic effects on type II collageninduced arthritis in rats. Pharm Biol, 56: 209-216. Mansoori P, Akhondzadeh S, Raisi F, Ghaeli P.2011. A randomized, double-blind, placebo-controlled study of safety of the adjunctive saffron on sexual dysfunction induced by a selective serotonin reuptake inhibitor. J Med Plant Res, 1: 121-130. Modaghegh M-H, Shahabian M, Esmaeili H-A, Rajbai O.2008. Safety evaluation of saffron (Crocus sativus) tablets in healthy volunteers. Phytomedicine, 15: 1032-1037. Moghimi N, Rahimi E, Ghaderi B, Saeeedi A.2014b. Relationship between platelet indices and severity of rheumatoid arthritis according to DAS28 criteria. Scientific J Kurdistan Univ Med Sci, 19: 1-8. Molina V, Shoenfeld Y.2005b. Infection, vaccines and other environmental triggers of autoimmunity. J Autoimmun, 38: 235- 245. Nair SC, Kurumboor S, Hasegawa J. 1995b. Saffron chemoprevention in biology and medicine: a review. Cancer Biother Radiopharm, 10: 257-264. Nazary-Moghadam S, Zeinalzadeh A, Salavati M, Almasi S, Negahban H. 2017. Adaptation, reliability and validity testing of a Persian version of the Health Assessment Questionnaire-Disability Index in Iranian patients with rheumatoid arthritis. J J Body Mov Ther, 21: 133-140. NG KP, AUSTIN P, AMERATUNGA R, McQUEEN F. 2006b. Role of anticycliccitrullinated peptide 2 assay in long‐standing rheumatoid arthritis. APLAR J Rheumatol, 9: 211-215. Padyukov L, Silva C, Stolt P, Alfredsson L. 2004. A gene–environment interaction between smoking and shared epitope genes in HLA–DR provides a high risk of seropositive rheumatoid arthritis. Arthritis Rheum, 50: 3085-3092. Rastmanesh R, Rabiee S, Shaabani Y, Mazinani H, Ebrahimi AA, Jamshidi AR. 2010b. Validation of the Persian version of the Stanford Health Assessment Questionnaire (HAQ) in patients with rheumatoid arthritis. J Paramed Sci, 1: 16-25. Rathore B, Jaggi K, Thakur SK, Mathur A. 2015b. Anti-inflammatory activity of Crocus sativus extract in experimental arthritis. Int J Pharm Sci Res, 6: 1473-1478. Sahebari M, Mahmoudi Z, Rabe SZT, Haghmorad D. 2011a. Inhibitory effect of aqueous extract of Saffron (Crocus sativus L.) on adjuvant-induced arthritis in Wistar rat. Pharmacologyonline, 3: 802-808. Schmidt M, Betti G, Hensel A. 2007. Saffron in phytotherapy: pharmacology and clinical uses. Wien Med Wochenschr, 157: 315. Tremblay I, Beaulieu Y, Bernier A, Crombez G, Laliberté S, Thibault P, Velly AM, Sullivan MJ. 2008. Pain catastrophizing scale for francophone adolescents: a preliminary validation. Pain Res Manag, 1; 13. Tobón GJ, Youinou P, Saraux A. 2010b. The environment, geo-epidemiology, and autoimmune disease: Rheumatoid arthritis. Autoimmun Rev, 9: A288-A292. Van Der Heijde D, Van Der Helm-Van, AH, Aletaha D, Bingham CO, Burmester GR, Dougados M, Emery P, Felson D, Knevel R, Kvien TK, Landewé RB. 2013a. EULAR definition of erosive disease in light of the 2010 ACR/EULAR rheumatoid arthritis classification criteria. Ann Rheum Dis, 72: 479-481. Yarijani ZM, Najafi H, Madani SH. 2016b. Protective effect of crocin on gentamicininduced nephrotoxicity in rats. Iran J Basic Med Sci, 19: 337. Zamani Taghizadeh Rabe S, Sahebari M, Mahmoudi Z, Hosseinzadeh H. 2015b. Inhibitory effect of Crocus sativus L. ethanol extract on adjuvant-induced arthritis. Food Agr Immunol, 26: 170-180 | ||
آمار تعداد مشاهده مقاله: 7,015 تعداد دریافت فایل اصل مقاله: 806 |